Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
HOXB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PPP1R15A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IDO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTN3A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FGB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM6A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WARS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAR1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEACAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LY6G6C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ST6GAL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADGRE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCL22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C19orf12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100129518 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on